These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28463853)

  • 1. The role of activists in access to HIV and tuberculosis treatment and prevention.
    Geffen N
    Curr Opin HIV AIDS; 2017 Jul; 12(4):398-402. PubMed ID: 28463853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barcelona 2002: law, ethics, and human rights. Using the law to improve access to treatments.
    Elliott R; Parmar S; Divan V; Berger J
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):88-94. PubMed ID: 14743817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
    Guennif S
    Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global access to treatment: achievements and challenges.
    Cameron E; Gupta A
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):59-71. PubMed ID: 14765514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What contribution have human rights approaches made to reducing AIDS-related vulnerability in sub-Saharan Africa? Exploring the case study of access to antiretrovirals.
    Forman L
    Glob Health Promot; 2013 Mar; 20(1 Suppl):57-63. PubMed ID: 23549704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 8. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barcelona 2002: law, ethics, and human rights. Advancing research and access to HIV vaccines: a framework for action.
    Avrett S
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):101-5. PubMed ID: 14743820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
    Jain D; Darrow JJ
    Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patents for antiretrovirals be waived in the developing world? Annual Varsity Medical Debate--London, 21 January 2011.
    Corrick F; Watson R; Budhdeo S
    Philos Ethics Humanit Med; 2011 Jul; 6():13. PubMed ID: 21740573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 400-million-dollar cost. Brazil.
    Cardoso R
    Integration; 1998; (57):16-7. PubMed ID: 12294618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Framework Convention on Global Health: A tool for empowering the HIV/AIDS movements in Senegal and South Africa.
    Scheepers E
    Health Hum Rights; 2013 Jun; 15(1):E87-95. PubMed ID: 25006094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigma, activism, and well-being among people living with HIV.
    Earnshaw VA; Rosenthal L; Lang SM
    AIDS Care; 2016; 28(6):717-21. PubMed ID: 26852785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Human Rights and the Science of Antiretroviral Medicine.
    Kavanagh M; Cohn J; Mabote L; Meier BM; Williams B; Russell A; Sikwese K; Baker B
    Health Hum Rights; 2015 Jun; 17(1):E76-90. PubMed ID: 26204587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to hepatitis C virus treatment: Lessons from implementation of strategies for increasing access to antiretroviral treatment.
    Assefa Y; Hill PS; Williams OD
    Int J Infect Dis; 2018 May; 70():65-68. PubMed ID: 29550446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement, "scriptural economies," and social justice: governing HIV/AIDS treatments by numbers in a fragile state, the Central African Republic (CAR).
    David PM
    Dev World Bioeth; 2017 Apr; 17(1):32-39. PubMed ID: 26841345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employing human rights frameworks to realize access to an HIV cure.
    Meier BM; Gelpi A; Kavanagh MM; Forman L; Amon JJ
    J Int AIDS Soc; 2015; 18(1):20305. PubMed ID: 26568056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-trial access to antiretrovirals: who owes what to whom?
    Millum J
    Bioethics; 2011 Mar; 25(3):145-54. PubMed ID: 19594728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activists give South African government AIDS plan ultimatum.
    AIDS Policy Law; 2002 Nov; 17(21):5. PubMed ID: 12484323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.